Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures
NCT ID: NCT02048891
Last Updated: 2015-06-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
3 participants
INTERVENTIONAL
2014-10-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to find out which approach may work better in IVF patients who experienced 4 IVF failures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian Response
NCT02144818
Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF
NCT02173977
IVF Treatment in Women With Immature Oocytes in Previous Cycle
NCT02368964
Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles
NCT02862782
Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration
NCT02330770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hCG trigger
Ovulation trigger with Ovitrelle 250 microgram, luteal support with vaginal progesterone: gel Crinone 8% daily.
hCG trigger
GnRH agonist trigger
ovulation trigger with Decapeptyl 0.2 mg, luteal support with 2 injections of 1,500 U hCG.
GnRH agonist trigger
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GnRH agonist trigger
hCG trigger
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* On trigger day, no more than 10 follicles of 12 mm and up
Exclusion Criteria
35 Years
44 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shahar Kol MD
Director, IVF Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVF Unit, Rambam medical Center
Haifa, Israel, Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RMB-0427-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.